Evolent Health (EVH) vs TriplePoint Venture Growth BDC (TPVG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
TriplePoint Venture Growth BDC (TPVG) has outperformed Evolent Health (EVH) over the past year, losing 16.2% versus a loss of 49.0%. Over five years, TPVG leads with a -72.2% price change compared with -86.2% for EVH. Evolent Health is the larger company by market cap ($451.7 million vs $190.5 million), about 2.4 times the size.
On valuation, TriplePoint Venture Growth BDC trades at a lower forward P/E (5.7x vs 9.9x for Evolent Health). TriplePoint Venture Growth BDC pays a dividend yielding 19.66%, while Evolent Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVH | TPVG |
|---|---|---|
| Share price | $4.00 | $4.68 |
| Market cap | $451.67M | $190.52M |
| 1-day change | -3.50% | +0.21% |
| YTD return | +3.50% | -28.59% |
| 1-year return | -49.01% | -16.16% |
| 5-year return | -86.17% | -72.22% |
| P/E ratio (TTM) | — | 4.73 |
| Forward P/E | 9.89 | 5.71 |
| EPS (TTM) | $-4.49 | $0.99 |
| Dividend yield | 0.00% | 19.66% |
| Annual dividend | $0.00 | $0.92 |
| 52-week high | $8.33 | $6.95 |
| 52-week low | $2.10 | $4.40 |
| Distance from 52-week high | -52.04% | -32.66% |
| Analyst consensus | buy | none |
| Avg. price target upside | +43.93% | +24.57% |
| Average volume | 2.99M | 227.46K |
| Shares outstanding | 113.06M | 40.71M |
| Employees | 4,200 | — |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Other Consumer Services | Other Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Evolent Health is about 2.4 times larger than TriplePoint Venture Growth BDC by market value ($451.67M vs $190.52M).
- TPVG has outperformed EVH by 32.9 percentage points over the past year.
- TriplePoint Venture Growth BDC offers a meaningfully higher dividend yield (19.66% vs 0.00%).
About Evolent Health
EVH stock →Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management.
Consumer Discretionary · Other Consumer Services · 4,200 employees
About TriplePoint Venture Growth BDC
TPVG stock →TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments.
Consumer Discretionary · Other Consumer Services
EVH vs TPVG FAQ
Which is bigger, Evolent Health or TriplePoint Venture Growth BDC?
Evolent Health (EVH) is larger, with a market capitalization of $451.67M compared with $190.52M for TriplePoint Venture Growth BDC (TPVG).
Which stock has performed better over the past year, EVH or TPVG?
TPVG returned -16.16% over the past 12 months, compared with -49.01% for EVH (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Evolent Health or TriplePoint Venture Growth BDC?
TriplePoint Venture Growth BDC pays a dividend yielding 19.66%, while Evolent Health does not currently pay a regular dividend.
Are Evolent Health and TriplePoint Venture Growth BDC in the same industry?
Yes. Both are classified in the Other Consumer Services industry within the Consumer Discretionary sector.